Kent Feldman, DPM
Foot Surgery · San Diego, CANPI 1932211570
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,610 of the $3,222 with a category attached, or 81.0%. 17 manufacturers reported payments, led by Paragon 28, Inc. at 34.8% of the total. Reporting peaked in 2022 at $1,686 and has fallen 97.0% since, to $50 in 2025.
Across 60 payments — averaging $53.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$1K
- Stryker$529
- Acera Surgical, Inc.$357
- Aroa Biosurgery Incorporated$309
- Treace Medical Concepts, Inc.$262
- Integra Lifesciences Corporation$211
- plus $434 from 11 others
What the payments were for
- Royalty or licence$391%
- Travel & lodging$57318%
- Food & beverage$2,61081%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 6 | $1,120 |
| Stryker(2 entities) | 7 | $529 |
| Acera Surgical, Inc. | 2 | $357 |
| Aroa Biosurgery Incorporated | 5 | $309 |
| Treace Medical Concepts, Inc. | 8 | $262 |
| Integra Lifesciences Corporation | 6 | $211 |
| Smith+Nephew | 5 | $73 |
| Zimmer Biomet | 4 | $70 |
| Tactile Systems Technology Inc | 4 | $57 |
| Arthrosurface Incorporated | 4 | $55 |
| Acumed LLC | 1 | $53 |
| Bioventus LLC | 3 | $51 |
| Acell, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $14 |
| Carbofix Orthopedics Inc | 1 | $14 |
| Biotissue Holdings Inc. | 1 | $14 |
| Trimed, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$1,067
- Restrata Wound Matrix$357
- ORTHOLOC 3DI$169
- PROstep$139
- 7 X 23MM CITRELOCK IMPLANT$139
- ORTHOLOC 2 LAPIFUSE$139
- AUGMENT$132
How this compares
$3,222 in reported general payments places this provider in the 80th percentile of 71 foot surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 18 | $247 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $157 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $145 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in San Diego
- Ingrid EdelmanSan Diego$6K
- Robert ValloneSan Diego$1K
- Daniel HsuSan Diego$554
- Alexander ReyzelmanSan Francisco$137K
- Helen ShnolBeverly Hills$22K
- Benedict ChingFountain Valley$19K
- Zachary KramerEncinitas$14K
- Tara HarringtonElk Grove$12K
- Jack MorganMonterey Park$11K
- Jaehyun KimSunnyvale$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.